Elahere suffered multiple development setbacks, including a failed Phase III study, but was ultimately granted accelerated approved by the FDA in ovarian ... making 17. The history of ADCs is ...

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

ImmunoGen, Inc. has announced that its platinum-resistant ovarian cancer drug ELAHERE (mirvetuximab soravtansine-gynx) has been granted FDA accelerated approval. This first FDA antibody-drug ...

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...

More than half (60%) of patients in latest trial reached active remission and 41% stopped taking corticosteroid entirely.

The FDA approved ribociclib (Kisqali) for adjuvant treatment of high-risk, hormone receptor-positive, HER2-negative early breast cancer. The FDA approved ribociclib (Kisqali) with an aromatase ...

Apple’s AirPods Pro 2 will soon function as over-the-counter (OTC) hearing aids for adults, following FDA approval. The update will amplify sound for those with mild to moderate hearing loss and ...

Withings has offered sleep apnea detection in devices for some time, while Samsung received FDA approval for its Galaxy Watch line earlier this. The feature arrives as another — blood oxygen ...

Sponsor Message The FDA approval came after a clinical study with 118 subjects with perceived mild to moderate hearing loss. The results showed that the subjects who used Apple's hearing aid ...

The FDA has approved the first over-the-counter (OTC) hearing aid software device for use with compatible versions of Apple Inc.’s (NASDAQ:AAPL) AirPods Pro headphones. Known as the Hearing Aid ...

Tecentriq Hybreza, a subcutaneous delivery of the drug, was approved for certain types of sarcoma, in addition to lung, skin and liver cancers. The Food and Drug Administration (FDA) approved ...